Inicio>>Signaling Pathways>> Others>>EtDO-P4

EtDO-P4

Catalog No.GC69085

EtDO-P4 es un inhibidor de síntesis de glucolípidos (GSL) a nivel nanomolar. EtDO-P4 inhibe la vía ERK inducida por EGFR y la activación de varios receptores tirosina quinasa (RTK). EtDO-P4 se puede utilizar en la investigación de diversos tipos de tumores, incluyendo el linfoma de Burkitt.

Products are for research use only. Not for human use. We do not sell to patients.

EtDO-P4 Chemical Structure

Cas No.: 245329-78-6

Tamaño Precio Disponibilidad Cantidad
10mg
162,00 $
Disponible
25mg
342,00 $
Disponible
50mg
585,00 $
Disponible
100mg
990,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Reseñas

Review for EtDO-P4

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for EtDO-P4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.